Rifamycin B

CAS: 13929-35-6

Ref. 3D-FR178810

Produktinformation

• Name: Rifamycin B
• Synonyme: 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan, rifamycin deriv., 4-O-(Carboxymethyl)rifamycin, Acetic acid, [(1,2-dihydro-5,6,17,19,21-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-9-yl)oxy]-, 21-acetate, NSC 145604, Nancimycin, Rifamycin, 4-O-(carboxymethyl)-, Rifomycin B, {[(14E,24E)-21-(acetyloxy)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-9-yl]oxy}acetic acid, {[(24E)-21-(acetyloxy)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-9-yl]oxy}acetic acid, {[(2S,16S,17S,18R,19R,20S,21S,22S,23S)-21-(acetyloxy)-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-9-yl]oxy}acetic acid

Beschreibung

Rifamycin B is a rifamycin antibiotic that inhibits the bacterial enzyme DNA-dependent RNA polymerase. It is used to treat infectious diseases, such as tuberculosis and staphylococcal infections. Rifamycin B has been shown to be active against methicillin-resistant Staphylococcus aureus (MRSA) and penicillin-resistant Streptococcus pneumoniae. The process optimization of rifamycin B was performed by reacting the compound with inorganic acid, p-hydroxybenzoic acid, and metal hydroxides in order to improve its antimicrobial activity profile. Rifamycin B has also been shown to be an effective agent against resistant mutants of bacteria through surface methodology experiments.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 755.8 g/mol
• Formel: C₃₉H₄₉NO₁₄
• Reinheit: Min. 95%
• Farbe/Form: Powder